Global Nanopore Sequencing Market Size was valued at USD 343.0 Mn in 2024 and is predicted to reach USD 1,949.5 Mn by 2034 at a 19.4% CAGR during the forecast period for 2025-2034.
Nanopore sequencing is a novel, scalable method that enables direct, real-time examination of lengthy DNA or RNA fragments. The technique operates by tracking how an electrical current changes when nucleic acids move through a protein nanopore. The resultant signal is often decoded to provide a particular sequence of DNA or RNA. The growing prevalence of genetic disorders, increasing demand for personalised medicine, and advancements in sequencing technology are the primary factors driving the market's rapid growth.
The market is growing, in large part, due to the potential uses of nanopore sequencing in various industries and its ability to deliver real-time data. Furthermore, the growth of biotechnology and pharmaceutical firms, population growth, improved healthcare facilities, and increasing public awareness of genetic illnesses all have a favourable impact on the nanopore sequencing industry.
Additionally, during the projection period, market participants would have more profitable opportunities due to the adoption of improved genetic treatments. However, worries about mistake rates are anticipated to hinder market expansion. During the forecast period, the nanopore sequencing market is expected to face challenges due to a shortage of skilled personnel.
Competitive Landscape
Some of the Major Key Players in the Nanopore Sequencing Market are:
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Pacific Biosciences
- Oxford Nanopore Technologies Limited
- QIAGEN
- F. Hoffmann-La Roche Ltd.
- PerkinElmer Inc.
- Thermo Fisher Scientific
- Eurofins Scientific
- Agilent Technologies, Inc.
- Myriad Genetics, Inc.
- Others
Market Segmentation:
The nanopore sequencing market is segmented based on product, type of nucleotide sequenced, type of nanopore, application, and end-user. Based on product, the market is segmented into instruments and consumables. By type of nucleotide sequenced, the market is segmented into DNA and RNA. By type of nanopore, the market is segmented into solid state, biological, and hybrid. By application, the market is segmented into clinical research, human genetics, animal research, and others. By end-user, the market is segmented into clinical laboratories, biotechnological companies, academic & research institutes, and others.
Based on the Product, the Consumables Segment is Accounted as a Major Contributor to the Nanopore Sequencing Market
The consumables segment is expected to hold a major global market share in 2024. The strong demand for kits and reagents is a primary driver of the dominance of consumables in the nanopore sequencing market. The increase in consumable usage is evident in various processes, including RNA and DNA sequencing. Additionally, these consumables are being used in hitherto undiscovered applications, which broadens their use and increases demand for them. The demand for dependable and effective consumables has increased in tandem with the development of nanopore sequencing technology. To ensure accurate and precise results in their genetic studies, scientists and researchers rely on these consumables.
Diagnostic Laboratories Segment to Witness Growth at a Rapid Rate
The DNA segment led the nanopore sequencing market in 2024. The increasing clinical benefits of nanopore technologies in DNA sequencing, rising technological breakthroughs, and expanding strategic actions by prominent market players are the main drivers propelling the expansion of the DNA sector. Additionally, the growing clinical uses of nanopore sequencing technologies for DNA sequencing are anticipated to boost their use, which will boost the revenue of the studied segment throughout the projected period.
In the Region, the North American Nanopore Sequencing Market Holds a Significant Revenue Share
The North American nanopore sequencing market is expected to register the highest market share in revenue in the near future because of its highly developed healthcare system, substantial R&D expenditures, and the presence of important industrial players. Growing genetic problems and government support for genomics and tailored medicine drive market growth. In addition, Asia Pacific is projected to grow rapidly in the global Nanopore Sequencing market because cutting-edge genomics technologies are being used in both clinical and research settings. Collaborations and strong research institutes foster innovation and commercial expansion. In the Asia-Pacific area, nanopore sequencing is expanding quickly due to investments in biotechnology and research.
Recent Development:
- September 2024: CycloneSEQ-WT02 and CycloneSEQ-WY01, two nanopore gene sequencing products, have been commercialized and distributed worldwide by MGI Tech Co., a Chinese firm. With a number of scientific advancements, including sophisticated protein engineering, a novel flow cell architecture, and a cutting-edge base calling algorithm, the CycloneSEQ technology exhibits promise in a variety of genomics domains. It is designed to achieve high sequencing accuracy and throughput.
- August 2024: Oxford Nanopore Technologies received an investment of GBP 50 million (USD 63 million) from Novo Holding. Through real-time workflows, Oxford Nanopore's analytical technology is being utilized for DNA and RNA sequencing, giving users insights into the epigenetics of a material. This investment demonstrated Oxford Nanopore's expanding potential in the biopharmaceutical industry and the company's faith in its technology.
Nanopore Sequencing Market Report Scope :
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 343.0 Mn |
|
Revenue Forecast In 2034 |
USD 1,949.5 Mn |
|
Growth Rate CAGR |
CAGR of 19.4% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Type Of Nucleotide Sequenced, By Type Of Nanopore, By Application, End-User. and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Bio-Rad Laboratories, Inc., Danaher Corporation, Pacific Biosciences, Oxford Nanopore Technologies Limited, QIAGEN, F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Thermo Fisher Scientific, Eurofins Scientific, Agilent Technologies, Inc., Myriad Genetics, Inc., and other prominent players. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
